Department of Urology, Sant'Andrea Hospital, "La Sapienza" University, Roma, Italy.
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Eur Urol Focus. 2017 Oct;3(4-5):352-363. doi: 10.1016/j.euf.2017.11.004. Epub 2017 Nov 27.
Lower urinary tract symptoms (LUTSs) and erectile dysfunction (ED) are substantial health concerns with a significant impact on the overall male quality of life.
To evaluate the available evidence of the association between LUTSs and ED in patients with benign prostatic hyperplasia (BPH), and discuss possible clinical implications for the management of LUTS/BPH.
A systematic review of the existing literature published between 1997 and June 2017 and available in the Medline, Scopus, and Web of Science databases was conducted using both the Medical Subject Heading (MeSH) and free-text protocols. The MeSH search was conducted by combining the following terms: "lower urinary tract symptoms," "LUTS," "benign prostatic hyperplasia," "BPH," "erectile dysfunction," "sexual dysfunction," "BPE," and "benign prostatic enlargement." The Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines were followed.
Several community-based studies in different geographical areas have provided strong evidence of an age-independent association between LUTSs and ED. Several biological mechanisms have been proposed to explain this association, but further research is required to better understand the molecular pathways involved. It is necessary to evaluate the possible impact of the metabolic syndrome treatment on LUTS/ED management. Considering the possible relationship between LUTSs and ED, their impact on the quality of life, and the possible adverse effects associated with LUTS medical treatment, clinicians should always evaluate ED in patients with LUTSs and take the opportunity to evaluate patients reporting ED for LUTSs.
Data from the peer-reviewed literature suggest the existence of an association between LUTS/BPH and ED, although their casual relationship has not been established yet. Emerging data also suggest that pathophysiological mechanisms involved in the metabolic syndrome are key factors in both disorders. Considering the association, it is also recommended that men presenting with LUTSs or ED should be evaluated for both disorders. A better understanding of the molecular pathways behind this association may also help identify new possible targets and develop novel therapeutic approaches to manage LUTSs and ED.
In this manuscript, we report on all the available evidence linking erectile dysfunction and lower urinary tract symptoms. Our findings suggest the existence of a strong relationship between these two conditions. On the basis of these findings, we recommend that clinicians always explore both conditions in male patients presenting with either of symptoms.
下尿路症状(LUTS)和勃起功能障碍(ED)是严重影响男性整体生活质量的重大健康问题。
评估良性前列腺增生(BPH)患者中 LUTS 和 ED 之间关联的现有证据,并讨论 LUTS/BPH 管理的可能临床意义。
对 1997 年至 2017 年 6 月期间发表的现有文献进行了系统评价,并检索了 Medline、Scopus 和 Web of Science 数据库,同时使用了医学主题词(MeSH)和自由文本方案。MeSH 搜索通过组合以下术语进行:“下尿路症状”、“LUTS”、“良性前列腺增生”、“BPH”、“勃起功能障碍”、“性功能障碍”、“BPE”和“良性前列腺增大”。遵循了系统评价和荟萃分析报告的首选项目。
不同地理区域的几项社区研究提供了强有力的证据,证明 LUTS 和 ED 之间存在与年龄无关的关联。已经提出了几种生物学机制来解释这种关联,但需要进一步研究以更好地了解涉及的分子途径。有必要评估代谢综合征治疗对 LUTS/ED 管理的可能影响。鉴于 LUTS 和 ED 之间可能存在的关系、它们对生活质量的影响以及 LUTS 治疗相关的潜在不良反应,临床医生应始终评估 LUTS 患者的 ED,并在报告 LUTS 的患者中评估 ED 的机会。
来自同行评议文献的数据表明,LUTS/BPH 和 ED 之间存在关联,尽管尚未确定其因果关系。新兴数据还表明,代谢综合征相关的病理生理机制是这两种疾病的关键因素。考虑到这种关联,还建议出现 LUTS 或 ED 的男性应同时评估这两种疾病。对这种关联背后的分子途径的更好理解也可能有助于识别新的可能靶点,并开发新的治疗方法来管理 LUTS 和 ED。
在本文中,我们报告了所有将勃起功能障碍与下尿路症状联系起来的现有证据。我们的研究结果表明,这两种疾病之间存在很强的关联。基于这些发现,我们建议临床医生在出现任何一种症状的男性患者中始终探索这两种疾病。